IBJNews

Endocyte's $86M IPO plan a boon for Indiana, investors

Back to TopCommentsE-mailPrintBookmark and Share
Greg Andrews

Endocyte Inc. has zero sales and a work force of just 54. But the fledgling life sciences firm may end up as one of Indiana’s most powerful economic engines of the 21st century.

Or at least that’s what many of the leaders of Indiana’s life sciences and entrepreneurial communities have been hoping for years. And now that the cancer-fighting West Lafayette firm has filed for an $86 million initial public offering, that reality seems tantalizingly close.

A successful IPO would be huge on many levels.

For the state of Indiana, it would help validate key parts of its economic-development strategy. From 2001 through 2004, the company received a total of $4 million in grants from the state’s 21st Century Research and Technology Fund—money that helped sustain it at a crucial time and drew in tens of millions of dollars more in venture capital.

Endocyte also demonstrates the potential payoff from the state’s push to transfer promising new technologies from academic laboratories to startup companies. Philip Low, a Purdue University chemistry professor who serves as Endocyte’s chief science officer, led the research team that developed the company’s treatment—an approach that delivers high doses of cancer drugs to diseased cells while leaving healthy cells untouched.

Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital, Clarian Health Ventures and the Indiana Future Fund.

The life sciences initiative BioCrossroads launched the Future Fund in 2003, raising $73 million from the Public Employees’ Retirement Fund, Ball State University, OneAmerica, WellPoint Inc. and others. The money then flowed to six venture capital firms, including San Francisco-based Burrill & Co., which became one of Endocyte’s biggest investors.

An even larger investor is the pension fund of the Indianapolis-based Christian Church (Disciples of Christ). Endocyte’s IPO filing, submitted to the Securities and Exchange Commission Aug. 17, said the fund invested more than $10.3 million and holds a 15-percent stake. Pension fund President James Hamlett declined to comment, citing regulatory restrictions while an IPO is pending.

P. Ron Ellis, Endocyte’s CEO, also declined to comment, citing the same restrictions.

The company’s 150-page IPO filing, however, tells an intriguing story—one of a company that slugged through years of research in its quest to bring a ground-breaking treatment to market. The company operates out of 14,000 square feet at Purdue University Research Park as well as a 4,000-square-foot corporate office in Indianapolis.

Here’s how Endocyte’s technology works: The cancer-fighting drug is linked to a substance that targets receptors that are overexpressed in diseased cells relative to healthy cells. Endocyte uses companion imaging technology to identify patients who have the overexpressed receptors and thus are more likely to benefit from treatment.

It’s a powerful combination. “This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone,” Endocyte says in its filing.

Endocyte now is on the cusp of commercialization. In early 2011, it expects to begin enrollment in a phase-three trial for an extremely difficult-to-treat form of ovarian cancer. Women receiving the treatment in a phase 2 trial saw a 105-percent improvement in progression-free survival compared with women receiving the standard therapy.

The company also is working on other treatments, including one for non-small-cell lung cancer that has completed a phase two trial.

For now, however, Endocyte is piling up massive losses, burning through the more than $90 million in private investment it’s raised since forming in 1995. Over just the past three years, losses have totaled $49 million. And there’s no guarantee of ultimate success, said David Menlow, president of IPOfinancial.com in Millburn, N.J.

He said life sciences firms often go public before their products have won U.S. Food and Drug Administration approval. Some ultimately succeed spectacularly, he said, while others flame out. Some investors stay on the sidelines “because they don’t feel like buying lottery tickets,” he said.

Yet economic development leaders are focusing on the upside—and what Endocyte’s long-term success would mean for efforts to cast Indiana as a hotbed for life sciences entrepreneurism.

“For us, as this moves ahead, it is proof of concept that Indiana companies can go the distance,” said David Johnson, CEO of BioCrossroads.

And—oh, yeah—there’s the potential benefit to humanity, too.

“The product itself has the promise of saving tens of thousands if not millions of lives in this country and around the world,” said Mitch Roob, Indiana’s secretary of commerce.•

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Uh, sorry Johnnie, but you are incorrect. Despite the assertions by yourself and various defenders and captains, sports attendance is NOT off significantly at most sporting events in the US. Variances in attendance has been in the range of single digits, both + & - for years now. MLB has had most of its best overall attendance nubers in the last decade, and that trend has been consistent for most major sporting events. The number one issue cited by most fans when asked about attendance is the overall cost of attending. The presence of HD and big screen televisions in home doesn't even register, as a factor for not attending an event. VALUE in the product is the key, and apparently is something lacking in the current ICS. What other explanation is there when with what is routinely touted as the "best" racing on the planet, fans are staying away in DROVES. A "close" title battle into the last event at Fontana, with the "cars and stars" of the ICS, and who showed up? MAYBE 8K. Sorry, but HD TV isn't to blame for that kind of fan apathy.

  2. Do you need finance to establish your business ? Are you interested in getting a loan at 3% from our private company? If so please Email: suntrust_oil@blumail.org

  3. If she was worth the $ the public outcry over direct tv dropping them would have kept them on their dishes as we have seen with other companies. I too quit watching channel 13 after she showed up since I left channel 8 because of her all show rather than production results. When Randy on 8 corrected her she had a big head and incorrectly challenged his correction for pronunciation of a city. Other antics while she matures was too much for me with her very inaccurate forecasts. All the forecasters were predicting rain until Thursday except Chris. They predicted sunny on Thursday but instead of rain until Thursday upon which the sun would finally make it out in full glory Chris was right on the money just as I too predicted looking at the radar on weather.gov. One thing I love about Angela is the fear you can see in her every time it thunders in the winter. It far exceeds the entertainment value of her body language (high heel noise drags, depression, etc) when her forecasts are so incorrect. Her hair stands on end, you have to see it!!!

  4. Good Day, Apply For A Loan I am Mr Fernadez Antonio, a private Loan lender and a cooperate financial for real estate and any kinds of business financing. I also offer Loans to individuals, Firms and cooperate bodies at 3% interest rate We offer any kind of loans. email us via fernadezloaninvest@outlook.com LOAN APPLICATION FORM First name:......................... Middle name:......................... Last name:........................................ Date of birth (yyyy-mm-dd):....................... Gender:........................................... Marital status:................................... Total Amount Needed............................... Loan Duration.................................... Address:.......................................... City:............................................. State/province:................................... Zip/postal code:.................................. Country:.......................................... Phone:............................................ Fax:.............................................. Mobile/cellular:.................................. Monthly Income.................................... Occupation:....................................... Best Regard, Mr Fernadez Antonio.

  5. i will love to share my testimony to you all the people in world i got married to my husband about 2 year ago we start having problems at home like we stop sleeping on the same bed,fighting about little things he always comes home late at night,drinking too much and sleeping with other women out side i have never love any man in my life except him. he is the father of my child and i don't want to loose him because we have worked so hard together to become what we are and have today .few month ago he now decided to live me and the kid,being a single mother can be hard sometimes and so i have nobody to turn to and i was heart broken.i called my mom and explain every thing to her,my mother told me about DR.okoro how he helped her solve the problem between her and my dad i was surprise about it because they have been without each other for three and a half years and it was like a miracle how they came back to each other. i was directed to DR. okoro on his email:okorospell@gmail.com and explain everything to him,so he promise me not to worry that he will cast a spell and make things come back to how we where so much in love again and that it was another female spirit that was controlling my husband he told me that my problem will be solved within two days if i believe i said OK So he cast a spell for me and after two days my love came back asking me to forgive him i Am so happy now. so that why i decided to share my experience with every body that have such problem contact Dr okoro the great spell caster on his email addresses spellcasterforlove@outlook.com

ADVERTISEMENT